Literature DB >> 8206506

The antigen self-presentation function of the cytotoxic T-cell clone 10BK.1 depends on reciprocal peptide presentation.

M S Staege1, T Dick, R Ertl, U Jahnel, H Nawrath, H G Rammensee, A B Reske-Kunz.   

Abstract

Cells of the cytotoxic T-cell clone 10BK.1 proliferate in response to ovalbumin (OVA) not only in the presence, but also in the absence, of antigen-presenting cells. This response is the consequence of reciprocal antigen presentation by two 10BK.1 cells. At the single-cell level, we found antigen-induced changes in the cytosolic Ca2+ concentration ([Ca2+]i) only in 10BK.1 cells that had contact with another 10BK.1 cell. This finding suggests that a single cell is unable to present the antigen to itself, and that two 10BK.1 cells are necessary and adequate to present the antigen to each other. Our data indicate that 10BK.1 cells are not capable of processing the OVA molecule. The naturally processed peptide OVA257-264 is a very potent antigen for these cells. A corresponding peptide seems to be present not only in preparations of native OVA, but also in preparations of the commonly used peptide OVA258-276. This 19mer peptide does not bind with high affinity to the relevant Kb class I molecule.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206506      PMCID: PMC1422339     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.

Authors:  V Barnaba; A Franco; A Alberti; R Benvenuto; F Balsano
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

2.  Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes.

Authors:  P R Walden; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

4.  Exact prediction of a natural T cell epitope.

Authors:  O Rötzschke; K Falk; S Stevanović; G Jung; P Walden; H G Rammensee
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

5.  Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.

Authors:  N A Hosken; M J Bevan; F R Carbone
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

Review 6.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

7.  Induction of antigen-specific CD8+ cytolytic T cells by the exogenous bacterial antigen streptolysin O in rhesus monkeys.

Authors:  C Chizzolini; P G Millet; M A Olsen-Rasmussen; W E Collins
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

8.  Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.

Authors:  K Heeg; W Kuon; H Wagner
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

9.  Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  1 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.